Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo
Cited by 17
Related Papers
Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
|British Journal of Cancer|2014|115
The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo
|PLoS ONE|2015|15
P-Glycoprotein-Evading Anti-tumor Activity of a Novel Tubulin and HSP90 Dual Inhibitor in a Non-small-cell Lung Cancer Model
|Journal of Pharmacological Sciences|2014|14